1/73
Looks like no tags are added yet.
penile stage 2
invades corpus spongiosum with or without urethral invasion
penile stage 3
invades corpora cavernosa with or without urethral invasion
penile stage 4
invades other adjacent structures such as scrotum, prostate, pubic bone
most common non-nodal sites of metastasis for penile cancer
liver, heart, lungs
prostate pT1
does not exist
prostate pT2
organ confined
prostate pT3
EPE, microscopic invasion of bladder neck, invasion of seminal vesicles
prostate pT4
tumor fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, pelvic wall
most common non-nodal sites of mets for prostate cancer
pelvic and lumbar spine
most common molecular alteration in prostate cancer
TMPRSS2-ERG
testes pT1
tumor limited to the testis without LVI
testes pT2
tumor limited to testes with LVI or tumor invading hilar ST or epididymis or penetrating visceral mesothelial layer covered the external surface of tunica albuginea with or without LVI
testes pT3
tumor directly invades spermatic cord ST with or without LVI
testes pT4
invades scrotum with or without LVI
most common site of mets for testicular cancer
lymph nodes, lung, liver, brain, bone
lung pT1
tumor less than or equal to 3 surrounded by lung or visceral pleura
lung pT2
tumor greater than 3 cm but less than or equal to 5 cm; involves any of the following: main bronchus, visceral pleura, associated with atelectasis or obstructive pneumonitis,
lung pT3
greater than 5 cm but less than or equal to 7 cm; involving any of the following: parietal pleura, chest wall, phrenic nerve, parietal pericardium, or separate nodule in the same lobe’
lung pT4
tumor greater than 7 or involves any of the following: diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal n, esophagus, vertebral body, carina; separate nodule in different lobe
lung PL1
tumor invasion beyond the elastic layer of the visceral pleura
lung PL2
tumor invasion to the visceral pleural surface
lung metastatic areas
adrenal, liver, bone, brain, other lung
adenocarcinoma presentation
solid, firm, grey/yellow, peripherally located, well-defined, women, non-smokers
squamous cell carcinoma presentation
white/grey, cauliflower-like, centrally located, central necrotic, males and smokers
most common molecular alterations for NSCLC
KRAS, EGFR, ALK
carcinoid tumor presentation
well-circumscribed, tan-white/pink, homogenous, most commonly within mainstream bronchi, MEN1
most common IHCs for carcinoid tumor
synaptophysin, chromogranin A
lung bx
88305
lung wedge
88307
total/lobe/segment resection
88309
paraglottic space
deep to ventricles
pre-epiglottic space
in front of the glottis
invasion of pre-epiglottic and/or paraglottic spaces means
pT3
pT4 for laryngeal tumors
through thyroid cartilage
what happens if laryngectomy frozen margins are positive
alters patient management and may mean post surgery radiation therapy
most important prognostic factor for laryngeal cancers
regional lymph node status
laryngeal cancer mets to
lung
larynx bx
88305
larynx, partial/total without nodes
88307
larynx, partial/total, with nodes
88309
most important prognostic factor for pharyngeal cancer
cervical lymph node status
oral cavity pT1
tumor less than or equal to 2cm, DOI less than or equal to 5mm
oral cavity pT2
tumor less than or equal to 2cm with DOI greater than 5mm
tumor greater than 2cm but less than 4 cm with DOI less than 10 mm
oral cavity pT3
tumor greater than 2cm but less than 4cm with DOI greater than 10 mm
tumor greater than 4cm with DOI less than 10 mm
oral cavity pT4
tumor greater than 4cm with DOI greater than 10 mm
or tumor invades cortical bone
strongest predictor of recurrence and survival for oral cavity cancer
margin status
tongue, excision for tumor
88309
mandible/maxilla, tumor resection
88309
lip, bx or wedge resection
88305
maxillary sinus pT1
limited to maxillary sinus mucosa with no erosion or destruction of bone
maxillary sinus pT2
tumor causes bone erosion or destruction including extension into the hard palate or middle nasal meatus
maxillary sinus pT3
tumor invades the following: bone of posterior maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses
maxillary sinus pT4
local disease; tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemportal fossa, cribriform plate, sphenoid, front sinuses, orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary, nasopharynx, clivus
radical neck dissection
includes levels I-V to include submandibular gland, SCM, IJV, spinal accessory nerve
modified radical neck dissection
levels I-V but spaces one or more of spinal accessory nerve, SCM, and IJV
selective neck dissection
less than 5 traditional levels
superselective neck dissection
fibrofatty elements of 2 levels or less
RLN for H&N criteria
one or multiple, ENE + or -, ipsilateral or contralateral nodes, size of metastatic deposit
lymph node excision
88307
lymph node regional resection
88307
most common thyroid cancer
PTC
most aggressive thyroid cancer
anapestic thyroid cancer
thyroid cancer arises from C cells
medullary thyroid cancer
thyroid pT1
limited to thyroid, less than or equal to 2 cm
thyroid pT2
limited to thyroid, greater than 2 but less than or equal to 4 cm
thyroid pT3
limited to thyroid and greater than 4 cm; or gross extrathyroidal extension invading only strap muscles
thyroid pT4
includes extra thyroidal extension beyond strap muscles
medullary thyroid cancer is associated with
MEN2 and RET mutations
thyroid resection
88307
salivary gland pT1
2 cm or smaller
salivary gland pT2
greater than 2 but less than or equal to 4 cm
salivary gland pT3
greater than 4 cm or has extraparenchymal extension
salivary gland pT4
advanced disease invading skin, mandible, ear canal, facial nerve, skull base or pterygoid plates, or encases carotid artery